Real-World Outcomes in Patients with Advanced Penile Squamous Cell Carcinoma Receiving Immune Checkpoint Inhibitors: A Single Institution Experience

Real-World Outcomes in Patients with Advanced Penile Squamous Cell Carcinoma Receiving Immune Checkpoint Inhibitors: A Single Institution Experience

Introduction Advanced penile squamous cell carcinoma (pSCC) is a rare and aggressive malignancy with a poor prognosis and an unmet need for biomarkers. We performed a retrospective evaluation of real-world efficacy, safety outcomes, and baseline inflammatory biomarkers in patients with advanced pSCC...

Full description

Saved in:
Bibliographic Details
Main Authors: Tony Z. Zhuang, Subir Goyal, Katherine B. Case, T. Anders Olsen, Shalini Vemuru, Ahmet Yildirim, Rohit V. Goswamy, Jacqueline T. Brown, Bradley C. Carthon, Omer Kucuk, Mehmet Asim Bilen, Viraj A. Master, Bassel Nazha
Format: Article
Language:English
Published: Innovative Healthcare Institute 2025-01-01
Series:Journal of Immunotherapy and Precision Oncology
Subjects:
penile squamous cell carcinoma
biomarker
immunotherapy
immune checkpoint inhibitor
nivolumab
pembrolizumab
Online Access:https://jipo.org/doi/pdf/10.36401/JIPO-24-19
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://jipo.org/doi/pdf/10.36401/JIPO-24-19

Similar Items